I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 13 studies | 22% ± 5% | |
| fibroblast | 8 studies | 21% ± 6% | |
| smooth muscle cell | 7 studies | 19% ± 4% | |
| ciliated cell | 6 studies | 26% ± 6% | |
| natural killer cell | 6 studies | 22% ± 4% | |
| basal cell | 6 studies | 25% ± 7% | |
| epithelial cell | 5 studies | 34% ± 13% | |
| CD8-positive, alpha-beta T cell | 5 studies | 17% ± 2% | |
| CD4-positive, alpha-beta T cell | 4 studies | 17% ± 1% | |
| hematopoietic precursor cell | 4 studies | 27% ± 7% | |
| glutamatergic neuron | 4 studies | 32% ± 16% | |
| pericyte | 4 studies | 24% ± 4% | |
| erythroblast | 4 studies | 36% ± 19% | |
| macrophage | 4 studies | 19% ± 1% | |
| astrocyte | 4 studies | 23% ± 3% | |
| non-classical monocyte | 3 studies | 23% ± 7% | |
| myofibroblast cell | 3 studies | 21% ± 5% | |
| erythrocyte | 3 studies | 27% ± 15% | |
| B cell | 3 studies | 22% ± 5% | |
| oligodendrocyte | 3 studies | 19% ± 2% |
